Quick Answer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Total Revenue of $4.02 billion for fiscal year 2025.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $4.02B -0.9% |
$4.05B -1.9% |
$4.13B +3.9% |
$3.98B +12.3% |
$3.54B +21.1% |
$2.92B +11.5% |
| Revenue (ASC 606) | $4.02B -0.9% |
$4.05B -1.9% |
$4.13B +3.9% |
$3.98B +12.3% |
$3.54B +21.1% |
$2.92B +11.5% |
| Net Income | -$144.34M -750.1% |
$22.20M -95.3% |
$474.62M -2.4% |
$486.23M +24.4% |
$390.98M +7.3% |
$364.30M +44.6% |
| Diluted EPS | -$2.91 -1555.0% |
$0.20 -97.8% |
$9.22 -2.7% |
$9.48 +24.7% |
$7.60 +5.6% |
$7.20 +42.0% |
| Total Assets | $7.14B -5.2% |
$7.53B -8.1% |
$8.20B +7.8% |
$7.60B +8.2% |
$7.02B +27.9% |
$5.49B +17.0% |
| Cash and Equivalents | $213.77M +9.8% |
$194.61M -29.7% |
$276.77M +18.3% |
$233.91M -3.0% |
$241.21M +5.6% |
$228.42M -4.0% |
| Stockholders Equity | $3.16B -8.6% |
$3.46B -3.8% |
$3.60B +20.9% |
$2.98B +17.4% |
$2.53B +19.9% |
$2.11B +29.4% |
| Operating Income | $25.16M -88.9% |
$227.35M -63.2% |
$617.26M -5.2% |
$650.98M +10.4% |
$589.86M +36.3% |
$432.73M +23.2% |
| Shares Outstanding | 49.22M -3.8% |
51.14M -0.4% |
51.34M +0.8% |
50.94M +0.9% |
50.48M +1.4% |
49.77M +1.7% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $1.00B | -0.5% | -2.6% |
| Revenue (ASC 606) | September 30, 2025 | $1.00B | -0.5% | -2.6% |
| Net Income | September 30, 2025 | $54.42M | -21.9% | +4.0% |
| Diluted EPS | September 30, 2025 | $1.10 | -17.3% | +3.8% |
| Total Assets | September 30, 2025 | $7.51B | -6.1% | -0.6% |
| Cash and Equivalents | September 30, 2025 | $207.10M | -1.5% | +13.3% |
| Stockholders Equity | September 30, 2025 | $3.41B | -10.0% | +1.6% |
| Operating Income | September 30, 2025 | $133.80M | +14.0% | +33.6% |
| Shares Outstanding | September 30, 2025 | 49.22M | -3.8% | +0.0% |
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Total Revenue of $4.02 billion for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -0.9% in Total Revenue compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Revenue (ASC 606) of $4.02 billion for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -0.9% in Revenue (ASC 606) compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Net Income of -$144.34 million for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -750.1% in Net Income compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Diluted EPS of $2.91 per share (loss) for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -1555.0% in Diluted EPS compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Total Assets of $7.14 billion for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -5.2% in Total Assets compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Cash and Equivalents of $213.77 million for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed an increase of +9.8% in Cash and Equivalents compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Stockholders Equity of $3.16 billion for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -8.6% in Stockholders Equity compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Operating Income of $25.16 million for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -88.9% in Operating Income compared to the prior fiscal year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. reported Shares Outstanding of 49.22 million shares for fiscal year 2025.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. showed a decrease of -3.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: